Test Price
550 AED✅ Home Collection Available
Immunohistochemistry CD7 (IHC CD7) Test in UAE | 550 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – Mobile home phlebotomy is disabled for this archival specimen type.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed specialist.
- Insurance & Billing: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CD7 immunohistochemistry (IHC) test is a specialized diagnostic procedure used to detect the CD7 antigen expression on T-cells within formalin-fixed, paraffin-embedded (FFPE) tissue biopsies. This test is critical for the differential diagnosis of T-cell lymphomas, leukemias, and specific immunodeficiency disorders. By providing morphological context alongside antigenic profiling, IHC CD7 offers significant advantages over flow cytometry in cases where fresh tissue is unavailable or when histological architecture must be preserved.
Our methodology utilizes validated monoclonal antibodies and automated staining platforms to ensure reproducible, high-contrast results. Where clinically indicated, we integrate optional TCR gene rearrangement analysis to confirm clonality.
| Feature | Our IHC CD7 Test (Premium) | Closest Alternative (Flow Cytometry CD7) |
|---|---|---|
| Method | Immunohistochemistry + optional TCR gene rearrangement analysis | Flow cytometry on fresh cells |
| Sample Suitability | FFPE tissue block or formalin‑fixed biopsy – archivable | Requires fresh tissue / immediate processing |
| Turnaround Time | 5‑7 business days (tissue block/large complex) | 24‑48 hours |
| Diagnostic Depth | Morphological context + clonality assessment | Limited phenotypic profile, no histology |
Physician Insight & Safety Protocols
“As a Specialist Diagnostic Radiologist, I evaluate a broad spectrum of oncologic imaging and tissue pathologies. The CD7 marker is essential for characterizing T-cell lymphoproliferative disorders. However, a diagnosis is never made on a single marker. We integrate IHC findings with clinical history, imaging, and other lab data to provide a comprehensive picture.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication & Treatment Advisory
Do not discontinue or alter any prescribed medications without consulting your treating physician. This test is a diagnostic aid intended for use alongside a comprehensive medical evaluation and should not be used as a standalone basis for therapy.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Known severe allergic reactions to formalin or local anesthetics must be disclosed before biopsy. The biopsy site must be infection‑free and the procedure performed under strict aseptic technique. Home collection is not suitable for self‑biopsy; only hospital‑grade tissue submission via our Secure Medical Courier Service is accepted.
- ER Red Flags: If you experience excessive bleeding, significant swelling, spreading redness, purulent discharge, or a fever following a biopsy, seek immediate emergency medical attention. Do not wait for test results to address acute symptoms.
Patient FAQ & Clinical Guidance
1. What is the CD7 immunohistochemistry test used for?
This test detects the CD7 antigen on tissue T-cells to help diagnose T-cell lymphomas and leukemias. It is typically ordered when a biopsy suggests a possible lymphoid malignancy, especially of T-cell origin. It can also clarify specific immunodeficiency states and guide targeted therapy decisions.
2. How should I prepare for the CD7 tissue biopsy sample collection?
The sample required is an FFPE block or tumor tissue fixed in 10% neutral-buffered formalin. No special diet or fasting is necessary. Our team will coordinate directly with your referring surgeon or hospital to arrange the Secure Medical Courier retrieval of the block and all required clinical documentation.
3. How long do results take, and who will interpret them?
Results are typically available within 5 to 7 business days. A comprehensive pathology report integrating the IHC findings, histomorphology, and clinical correlation will be issued. Every patient receives a telephonic consultation with a DHA-licensed specialist to clearly explain the results and outline any recommended next steps.
UAE Regulatory & Data Privacy Adherence
🔒 Legal & Quality Compliance Framework
We strictly adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing safety and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility operates under ISO 9001:2015 accreditation (Cert: INT/EGQ/2509DA/3139) and holds DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry CD7 (IHC CD7) |
| Price (AED) | 550 AED |
| Turnaround Time | 5-7 Business Days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Biopsy Slides (Archival Specimen) |
| Methodology Used | Immunohistochemistry (IHC) with optional TCR gene rearrangement analysis |
| ICD-10-CM Code | C84.4, C91.5, Z15.0 |
| LOINC Code | 57091-1 |
| DHA Facility License & Laboratory Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians